Inscription Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Sell |
7,146
-2,934
| -29% | -$136K | 0.05% | 330 |
|
|
2025
Q1 | $547K | Buy |
+10,080
| New | +$547K | 0.09% | 168 |
|
|
2024
Q3 | $610K | Sell |
11,791
-554
| -4% | -$28.7K | 0.09% | 164 |
|
|
2024
Q2 | $513K | Buy |
12,345
+2,265
| +22% | +$94.1K | 0.08% | 174 |
|
|
2024
Q1 | $547K | Buy |
10,080
+3,920
| +64% | +$213K | 0.09% | 168 |
|
|
2023
Q4 | $316K | Buy |
6,160
+860
| +16% | +$44.1K | 0.09% | 164 |
|
|
2023
Q3 | $308K | Buy |
5,300
+74
| +1% | +$4.3K | 0.1% | 143 |
|
|
2023
Q2 | $334K | Sell |
5,226
-115
| -2% | -$7.35K | 0.1% | 142 |
|
|
2023
Q1 | $370K | Buy |
5,341
+545
| +11% | +$37.8K | 0.1% | 140 |
|
|
2022
Q4 | $345K | Hold |
4,796
| – | – | 0.12% | 146 |
|
|
2022
Q3 | $341K | Sell |
4,796
-3,984
| -45% | -$283K | 0.1% | 139 |
|
|
2022
Q2 | $676K | Buy |
8,780
+4,500
| +105% | +$346K | 0.12% | 122 |
|
|
2022
Q1 | $315K | Sell |
4,280
-25
| -0.6% | -$1.84K | 0.09% | 155 |
|
|
2021
Q4 | $268K | Buy |
4,305
+270
| +7% | +$16.8K | 0.07% | 187 |
|
|
2021
Q3 | $241K | Sell |
4,035
-11,957
| -75% | -$714K | 0.08% | 189 |
|
|
2021
Q2 | $1.07M | Buy |
15,992
+11,767
| +279% | +$787K | 0.12% | 125 |
|
|
2021
Q1 | $269K | Buy |
4,225
+350
| +9% | +$22.3K | 0.09% | 159 |
|
|
2020
Q4 | $242K | Buy |
3,875
+50
| +1% | +$3.12K | 0.09% | 156 |
|
|
2020
Q3 | $231K | Buy |
+3,825
| New | +$231K | 0.1% | 149 |
|
|
2019
Q2 | – | Sell |
-350
| Closed | -$17K | – | 119 |
|
|
2019
Q1 | $17K | Sell |
350
-454
| -56% | -$22.1K | 0.01% | 225 |
|
|
2018
Q4 | $42K | Buy |
+804
| New | +$42K | 0.02% | 202 |
|